Clarus Lifesciences II, L.P. Insider Trading $TLOG TETRALOGIC PHARMACEUTICALS Corp
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Clarus Lifesciences II, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Clarus Lifesciences II, L.P.. Clarus Lifesciences II, L.P. is 10% Owner in ACHILLION PHARMACEUTICALS INC ($ACHN) and 10% Owner in AERIE PHARMACEUTICALS INC ($AERI) and 10% Owner in TETRALOGIC PHARMACEUTICALS CORP ($TLOG) and 10% Owner in Blackstone Group L.P. ($BX) and 10% Owner in NanoString Technologies Inc ($NSTG) and 10% Owner in Ophthotech Corp. ($OPHT) and 10% Owner in Restoration Robotics Inc ($HAIR) and 10% Owner in CATABASIS PHARMACEUTICALS INC ($CATB).
Clarus Lifesciences II, L.P. in TETRALOGIC PHARMACEUTICALS Corp
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Clarus Lifesciences II, L.P.: 10% Owner
Holdings: 2,214,523 shares
Current Value: $132,871
Latest Transaction: Feb 10 2016
$TLOG Market Capitalization: $1.49M
$TLOG Previous Close: $0.06
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Clarus Lifesciences II, L.P. in TETRALOGIC PHARMACEUTICALS Corp
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACHN, AERI, BX, CATB, OPHT, NSTG, TLOG, VERO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 10 2016 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 0.16 | 230,507 | 36,881 | 2,214,523 | 2.4 M to 2.2 M (-9.43 %) |
| Feb 10 2016 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 0.19 | 103,123 | 19,593 | 2,445,030 | 2.5 M to 2.4 M (-4.05 %) |
| Feb 05 2016 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 0.20 | 832,881 | 166,576 | 2,548,153 | 3.4 M to 2.5 M (-24.63 %) |
| Feb 05 2016 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 0.14 | 500,026 | 70,004 | 3,381,034 | 3.9 M to 3.4 M (-12.88 %) |
| Feb 05 2016 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 0.15 | 82,583 | 12,387 | 3,881,060 | 4 M to 3.9 M (-2.08 %) |
| Feb 02 2016 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 0.17 | 176,306 | 29,972 | 3,963,643 | 4.1 M to 4 M (-4.26 %) |
| Feb 02 2016 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 0.20 | 140,000 | 28,000 | 4,139,949 | 4.3 M to 4.1 M (-3.27 %) |
| Feb 02 2016 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 0.26 | 52,826 | 13,735 | 4,279,949 | 4.3 M to 4.3 M (-1.22 %) |
| Jan 28 2016 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 0.26 | 32,521 | 8,455 | 4,332,775 | 4.4 M to 4.3 M (-0.74 %) |
| Jan 28 2016 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 0.27 | 209,984 | 56,696 | 4,365,296 | 4.6 M to 4.4 M (-4.59 %) |
| Jan 28 2016 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 0.30 | 69,425 | 20,828 | 4,575,280 | 4.6 M to 4.6 M (-1.49 %) |
| Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Option Exercise | X | 6.40 | 23,282 | 149,056 | 0 | |
| Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Option Exercise | C | 7.00 | 853,416 | 5,973,912 | 0 | |
| Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,342,944 | 0 | 0 | |
| Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | X | 6.40 | 23,282 | 149,056 | 4,644,705 | 4.6 M to 4.6 M (+0.50 %) |
| Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | C | 7.00 | 853,416 | 5,973,912 | 4,621,423 | 3.8 M to 4.6 M (+22.65 %) |
| Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | C | 0.00 | 2,342,944 | 0 | 3,768,007 | 1.4 M to 3.8 M (+164.41 %) |
| Dec 19 2013 | TLOG | TETRALOGIC PHARMAC ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | P | 7.00 | 1,425,063 | 9,975,441 | 1,425,063 | 0 to 1.4 M |
Page: 1